{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:49:51Z","timestamp":1794037791679,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Her Majesty\u2019s Government UK through the Department of Business Energy and Industrial Strategy","id":[{"id":"https:\/\/ror.org\/019ya6433","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1038\/s41591-022-01780-9","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T06:04:10Z","timestamp":1648706650000},"page":"1031-1041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":482,"title":["Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults"],"prefix":"10.1038","volume":"28","author":[{"given":"Ben","family":"Killingley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3744-4604","authenticated-orcid":false,"given":"Alex J.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Kalinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Boyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niluka","family":"Goonawardane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Lindsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanjit S.","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6849-3962","authenticated-orcid":false,"given":"Jonathan","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Frise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Noulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"L\u00f6ndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Harden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-5142","authenticated-orcid":false,"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Baillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Charman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Mande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Nguyen-Van-Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-0418","authenticated-orcid":false,"given":"Malcolm G.","family":"Semple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4297-6728","authenticated-orcid":false,"given":"Robert C.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1154-8093","authenticated-orcid":false,"given":"Neil M.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7220-2555","authenticated-orcid":false,"given":"Peter J.","family":"Openshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5795-6500","authenticated-orcid":false,"given":"Garth","family":"Rapeport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3948-0895","authenticated-orcid":false,"given":"Wendy S.","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Catchpole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0914-920X","authenticated-orcid":false,"given":"Christopher","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"1780_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(21)00799-6","volume":"398","author":"TM Drake","year":"2021","unstructured":"Drake, T. M. et al. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet 398, 223\u2013237 (2021).","journal-title":"Lancet"},{"key":"1780_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99\u2013111 (2021).","journal-title":"Lancet"},{"key":"1780_CR3","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","volume":"385","author":"SJ Thomas","year":"2021","unstructured":"Thomas, S. J. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 Months. N. Engl. J. Med. 385, 1761\u20131773 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1780_CR4","doi-asserted-by":"publisher","first-page":"eabl7430","DOI":"10.1126\/scitranslmed.abl7430","volume":"14","author":"WA Fischerii","year":"2022","unstructured":"Fischerii, W. A. et al. A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. Sci. Transl. Med. 14, eabl7430 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1780_CR5","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/jmv.26326","volume":"93","author":"J He","year":"2021","unstructured":"He, J., Guo, Y., Mao, R. & Zhang, J. Proportion of asymptomatic coronavirus disease 2019: a systematic review and meta-analysis. J. Med. Virol. 93, 820\u2013830 (2021).","journal-title":"J. Med. Virol."},{"key":"1780_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","volume":"26","author":"X He","year":"2020","unstructured":"He, X. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 26, 672\u2013675 (2020).","journal-title":"Nat. Med."},{"key":"1780_CR7","doi-asserted-by":"publisher","first-page":"587374","DOI":"10.3389\/fpubh.2020.587374","volume":"8","author":"G Syangtan","year":"2020","unstructured":"Syangtan, G. et al. Asymptomatic SARS-CoV-2 carriers: a systematic review and meta-analysis. Front. Public Health 8, 587374 (2020).","journal-title":"Front. Public Health"},{"key":"1780_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10224","volume":"6","author":"A Jozwik","year":"2015","unstructured":"Jozwik, A. et al. RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat. Commun. 6, 10224 (2015).","journal-title":"Nat. Commun."},{"key":"1780_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1164\/rccm.202103-0620OC","volume":"204","author":"S Paterson","year":"2021","unstructured":"Paterson, S. et al. Innate-like gene expression of lung-resident memory CD8. Am. J. Respir. Crit. Care Med. 204, 826\u2013841 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1780_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/jmv.1890130208","volume":"13","author":"SE Reed","year":"1984","unstructured":"Reed, S. E. The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains. J. Med. Virol. 13, 179\u2013192 (1984).","journal-title":"J. Med. Virol."},{"key":"1780_CR11","doi-asserted-by":"publisher","first-page":"eaba9301","DOI":"10.1126\/science.aba9301","volume":"370","author":"MS Habibi","year":"2020","unstructured":"Habibi, M. S. et al. Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection. Science 370, eaba9301 (2020).","journal-title":"Science"},{"key":"1780_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1164\/rccm.201002-0221OC","volume":"182","author":"JP DeVincenzo","year":"2010","unstructured":"DeVincenzo, J. P. et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 182, 1305\u20131314 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1780_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3851\/IMP2629","volume":"18","author":"B Bagga","year":"2013","unstructured":"Bagga, B. et al. Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals. Antivir. Ther. 18, 785\u2013791 (2013).","journal-title":"Antivir. Ther."},{"key":"1780_CR14","doi-asserted-by":"publisher","first-page":"e1008704","DOI":"10.1371\/journal.ppat.1008704","volume":"16","author":"JS Nguyen-Van-Tam","year":"2020","unstructured":"Nguyen-Van-Tam, J. S. et al. Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environment. PLoS Pathog. 16, e1008704 (2020).","journal-title":"PLoS Pathog."},{"key":"1780_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/jama.1919.02610310005002","volume":"73","author":"M Rosenau","year":"1919","unstructured":"Rosenau, M. Experiments to determine mode of spread of influenza. JAMA 73, 311\u2013313 (1919).","journal-title":"JAMA"},{"key":"1780_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1056\/NEJMp2106970","volume":"385","author":"G Rapeport","year":"2021","unstructured":"Rapeport, G. et al. SARS-CoV-2 human challenge studies\u2014establishing the model during an evolving pandemic. N. Engl. J. Med. 385, 961\u2013964 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1780_CR17","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/cid\/ciaa1290","volume":"72","author":"MM Levine","year":"2021","unstructured":"Levine, M. M. et al. Viewpoint of a WHO advisory group tasked to consider establishing a closely-monitored challenge model of coronavirus disease 2019 (COVID-19) in healthy volunteers. Clin. Infect. Dis. 72, 2035\u20132041 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"1780_CR18","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1056\/NEJMp2020076","volume":"383","author":"ME Deming","year":"2020","unstructured":"Deming, M. E., Michael, N. L., Robb, M., Cohen, M. S. & Neuzil, K. M. Accelerating development of SARS-CoV-2 vaccines\u2014the role for controlled human infection models. N. Engl. J. Med. 383, e63 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1780_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1473-3099(21)00648-4","volume":"22","author":"A Singanayagam","year":"2021","unstructured":"Singanayagam, A. et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect. Dis. 22, 183\u2013195 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1780_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.biologicals.2020.08.006","volume":"67","author":"M Baay","year":"2020","unstructured":"Baay, M. & Neels, P. SARS-CoV-2 controlled human infection models: ethics, challenge agent production and regulatory issues. Biologicals 67, 69\u201374 (2020).","journal-title":"Biologicals"},{"key":"1780_CR21","doi-asserted-by":"publisher","first-page":"e2115352","DOI":"10.1001\/jamanetworkopen.2021.15352","volume":"4","author":"M Renaud","year":"2021","unstructured":"Renaud, M. et al. Clinical outcomes for patients with anosmia 1 year after COVID-19 diagnosis. JAMA Netw. Open 4, e2115352 (2021).","journal-title":"JAMA Netw. Open"},{"key":"1780_CR22","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1073\/pnas.2009799117","volume":"117","author":"M Imai","year":"2020","unstructured":"Imai, M. et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl Acad. Sci. USA 117, 16587\u201316595 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1780_CR23","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","volume":"583","author":"SF Sia","year":"2020","unstructured":"Sia, S. F. et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 583, 834\u2013838 (2020).","journal-title":"Nature"},{"key":"1780_CR24","doi-asserted-by":"publisher","first-page":"103403","DOI":"10.1016\/j.ebiom.2021.103403","volume":"68","author":"R Abdelnabi","year":"2021","unstructured":"Abdelnabi, R. et al. Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters. EBioMedicine 68, 103403 (2021).","journal-title":"EBioMedicine"},{"key":"1780_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","volume":"182","author":"YJ Hou","year":"2020","unstructured":"Hou, Y. J. et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182, 429\u2013446 (2020).","journal-title":"Cell"},{"key":"1780_CR26","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1080\/22221751.2020.1858177","volume":"9","author":"K Rosenke","year":"2020","unstructured":"Rosenke, K. et al. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Emerg. Microbes Infect. 9, 2673\u20132684 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"1780_CR27","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","volume":"383","author":"KS Corbett","year":"2020","unstructured":"Corbett, K. S. et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. N. Engl. J. Med. 383, 1544\u20131555 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1780_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-2423-5","volume":"585","author":"BN Williamson","year":"2020","unstructured":"Williamson, B. N. et al. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature 585, 273\u2013276 (2020).","journal-title":"Nature"},{"key":"1780_CR29","doi-asserted-by":"publisher","first-page":"e2111477118","DOI":"10.1073\/pnas.2111477118","volume":"118","author":"R Ke","year":"2021","unstructured":"Ke, R., Zitzmann, C., Ho, D. D., Ribeiro, R. M. & Perelson, A. S. In vivo kinetics of SARS-CoV-2 infection and its relationship with a person\u2019s infectiousness. Proc. Natl Acad. Sci. USA 118, e2111477118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1780_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1056\/NEJMc2027040","volume":"384","author":"MC Kim","year":"2021","unstructured":"Kim, M. C. et al. Duration of culturable SARS-CoV-2 in hospitalized patients with Covid-19. N. Engl. J. Med. 384, 671\u2013673 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1780_CR31","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJMc2001737","volume":"382","author":"L Zou","year":"2020","unstructured":"Zou, L. et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 382, 1177\u20131179 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1780_CR32","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/infdis\/jiaa077","volume":"221","author":"P Yu","year":"2020","unstructured":"Yu, P., Zhu, J., Zhang, Z. & Han, Y. A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. J. Infect. Dis. 221, 1757\u20131761 (2020).","journal-title":"J. Infect. Dis."},{"key":"1780_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/M20-0504","volume":"172","author":"SA Lauer","year":"2020","unstructured":"Lauer, S. A. et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann. Intern. Med. 172, 577\u2013582 (2020).","journal-title":"Ann. Intern. Med."},{"key":"1780_CR34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/1073858420956905","volume":"27","author":"R Butowt","year":"2020","unstructured":"Butowt, R. & von Bartheld, C. S. Anosmia in COVID-19: underlying mechanisms and assessment of an olfactory route to brain infection. Neuroscientist 27, 582\u2013603 (2020).","journal-title":"Neuroscientist"},{"key":"1780_CR35","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of Covid-19\u2014final report. N. Engl. J. Med. 383, 1813\u20131826 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1780_CR36","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.7326\/M21-0653","volume":"174","author":"A Barratt-Due","year":"2021","unstructured":"Barratt-Due, A. et al. Evaluation of the effects of remdesivir and hydroxychloroquine on viral clearance in COVID-19: a randomized trial. Ann. Intern. Med. 174, 1261\u20131269 (2021).","journal-title":"Ann. Intern. Med."},{"key":"1780_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","volume":"386","author":"RL Gottlieb","year":"2022","unstructured":"Gottlieb, R. L. et al. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N. Engl. J. Med. 386, 305\u2013315 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1780_CR38","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/v12091045","volume":"12","author":"KA Eberhardt","year":"2020","unstructured":"Eberhardt, K. A. et al. RNAemia corresponds to disease severity and antibody response in hospitalized COVID-19 patients. Viruses 12, 1045 (2020).","journal-title":"Viruses"},{"key":"1780_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19057-5","volume":"11","author":"J Fajnzylber","year":"2020","unstructured":"Fajnzylber, J. et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat. Commun. 11, 5493 (2020).","journal-title":"Nat. Commun."},{"key":"1780_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1473-3099(20)30985-3","volume":"21","author":"M Marks","year":"2021","unstructured":"Marks, M. et al. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Lancet Infect. Dis. 21, 629\u2013636 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1780_CR41","doi-asserted-by":"publisher","first-page":"2002724","DOI":"10.1183\/13993003.02724-2020","volume":"58","author":"D Munker","year":"2021","unstructured":"Munker, D. et al. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients. Eur. Respir. J. 58, 2002724 (2021).","journal-title":"Eur. Respir. J."},{"key":"1780_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jinf.2020.06.067","volume":"81","author":"KA Walsh","year":"2020","unstructured":"Walsh, K. A. et al. SARS-CoV-2 detection, viral load and infectivity over the course of an infection. J. Infect. 81, 357\u2013371 (2020).","journal-title":"J. Infect."},{"key":"1780_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/cid\/ciaa1157","volume":"73","author":"S Baggio","year":"2021","unstructured":"Baggio, S. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load in the upper respiratory tract of children and adults with early acute coronavirus disease 2019 (COVID-19). Clin. Infect. Dis. 73, 148\u2013150 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"1780_CR44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469 (2020).","journal-title":"Nature"},{"key":"1780_CR45","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/s41591-021-01575-4","volume":"27","author":"M Levine-Tiefenbrun","year":"2021","unstructured":"Levine-Tiefenbrun, M. et al. Viral loads of delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2. Nat. Med. 27, 2108\u20132110 (2021).","journal-title":"Nat. Med."},{"key":"1780_CR46","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/S2468-2667(20)30308-X","volume":"6","author":"BJ Quilty","year":"2021","unstructured":"Quilty, B. J. et al. Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study. Lancet Public Health 6, e175\u2013e183 (2021).","journal-title":"Lancet Public Health"},{"key":"1780_CR47","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2147\/CLEP.S311977","volume":"13","author":"I Petersen","year":"2021","unstructured":"Petersen, I., Crozier, A., Buchan, I., Mina, M. J. & Bartlett, J. W. Recalibrating SARS-CoV-2 antigen rapid lateral flow test relative sensitivity from validation studies to absolute sensitivity for indicating individuals shedding transmissible virus. Clin. Epidemiol. 13, 935\u2013940 (2021).","journal-title":"Clin. Epidemiol."},{"key":"1780_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01670-2","volume":"18","author":"D Gbesemete","year":"2020","unstructured":"Gbesemete, D. et al. Exploring the acceptability of controlled human infection with SARSCoV2\u2014a public consultation. BMC Med. 18, 209 (2020).","journal-title":"BMC Med."},{"key":"1780_CR49","doi-asserted-by":"publisher","unstructured":"Barker, C. et al. Public attitudes to a human challenge study with SARS-CoV-2: a mixed-methods study. Preprint at https:\/\/doi.org\/10.12688\/wellcomeopenres.17516.1 (2022).","DOI":"10.12688\/wellcomeopenres.17516.1"},{"key":"1780_CR50","doi-asserted-by":"publisher","first-page":"m3731","DOI":"10.1136\/bmj.m3731","volume":"371","author":"AK Clift","year":"2020","unstructured":"Clift, A. K. et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ 371, m3731 (2020).","journal-title":"BMJ"},{"key":"1780_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3758\/BF03210709","volume":"45","author":"RL Doty","year":"1989","unstructured":"Doty, R. L., Frye, R. E. & Agrawal, U. Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept. Psychophys. 45, 381\u2013384 (1989).","journal-title":"Percept. Psychophys."},{"key":"1780_CR52","unstructured":"Coronavirus Clinical Characterisation Consortium. Site set-up. ISARIC 4C https:\/\/isaric4c.net\/protocols"},{"key":"1780_CR53","unstructured":"Center for Disease Control and Prevention. CDC\u2019s Diagnostic Test for COVID-19 Only and Supplies. COVID-19 https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/virus-requests.html (2021)."},{"key":"1780_CR54","unstructured":"Zar, J. H. Biostatistical Analysis 5th edn (Pearson, 2010)."},{"key":"1780_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"K-Y Liang","year":"1986","unstructured":"Liang, K.-Y. & Zeger, S. L. Longitudinal data analysis using generalized linear models. Biometrika 73, 13\u201322 (1986).","journal-title":"Biometrika"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-01780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-01780-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-01780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T16:05:44Z","timestamp":1652889944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-01780-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1780"],"URL":"https:\/\/doi.org\/10.1038\/s41591-022-01780-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1121993\/v1","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"28 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.B., A.P.C., A.M., B.Z.L., M.K. and N.N. are employees of hVIVO Services Ltd. and hold shares in Open Orphan and Poolbeg Pharma. A.G. is previous employee at hVIVO Services Ltd. and holds shares in Open Orphan and Poolbeg Pharma. G.R. is a co-founder of SubIntro Ltd. M.G.S. is Director of MedEx Solutions Ltd., chairs the Infectious Disease Scientific Advisory Board of Integrum Scientific LLC and holds shares in Integrum Scientific LLC and MedEx Solutions Ltd. T.W. has received research grants and\/or fees from AstraZeneca, UCB, Bergenbio, Synairgen, Valneva and my mhealth (MMH) in the field of COVID-19 research. T.W. owns shares in Open Orphan and MMH. T.W. is a director of MMH. J.S.N.-V.-T. is seconded to the Department of Health and Social Care, England.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}